This site is intended for Healthcare professionals only.

Suven gets product patents from Aripo and South Korea


Suven gets product patents from Aripo and South Korea

New Delhi: Suven Life Sciences has secured a product patent each from African Regional Intellectual Property Organisation (Aripo) and South Korea corresponding to new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.

The two patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.

“We are pleased by the grant of these patents to Suven for our pipeline of molecules in the central nervous system (CNS) arena, which is being developed for cognitive disorders with high unmet medical need with a huge market potential globally,” Suven Life CEO Venkat Jasti said.
According to the company, the granted claims of the patents are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Parkinson, and Schizophrenia.



Source: PTI
0 comment(s) on Suven gets product patents from Aripo and South Korea

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted